Aurisco Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 302.14 million compared to CNY 218.83 million a year ago. Revenue was CNY 302.14 million compared to CNY 218.83 million a year ago.

Net income was CNY 45.88 million compared to CNY 40.85 million a year ago. Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.1 a year ago. Diluted earnings per share from continuing operations was CNY 0.11 compared to CNY 0.1 a year ago.